Shelston IP congratulates Prof Hala Zreiqat from Sydney University

Shelston IP wishes to congratulate Professor Hala Zreiqat from Sydney University, who has recently been named NSW Premier’s Woman of the Year.  She is currently Professor of Biomedical Engineering, where she founded the Tissue Engineering and Biomaterials Research Unit in 2006.   Shelston IP has been providing IP-related services to Sydney University for many years, and has been

New Zealand – Amendments to the Patents Regulations 2014 clear up a few uncertainties

New Zealand’s new Patents Act 2013 commenced on 13 September 2014, and was given effect by the accompanying Patents Regulations 2014.  Over the ensuing 3½ years, a few “uncertainties” (unintended consequences/drafting errors) have come to light.  On balance, none were deemed significant enough to warrant immediate amendment to the Regulations and indeed only one (micro-organism

The CPTPP has been signed – no United States and “IP Lite”

The “CPTPP”, otherwise known as the Comprehensive and Progressive Agreement for Trans-Pacific Partnership is what remains of the “TPPA-11” (which was itself, what remained of the  Trans-Pacific Partnership (“TPP”) Free Trade Agreement following the withdrawal of the United States).  Earlier today (8 March 2018), in Santiago, Chile, the eleven remaining signatories put pen to paper

The “gene patent” dichotomy between the US and Australia

The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between Australian and US “gene patent” practice into sharp focus. These differences predominantly arise from the peculiarities of the US and AU Myriad decisions as well as the US Mayo v. Prometheus and Ariosa v.

(Pods)Under Pressure: Cantarella Bros Pty Ltd v Koninklijke Douwe Egberts B.V. [2018] APO 15

Executive Summary A patent application withdrawn before its publication can still form part of the prior art base if it is subsequently claimed as a priority document for a later published patent application. Claim construction and expert evidence remain important in establishing whether the claims are novel or inventive. Applicants should ensure consistent use of

Where else can I secure protection via my European patent application?

Did you know that a European patent application can be used to secure protection reaching beyond the EPC member states?  Perhaps surprisingly, a European patent application can be used to obtain protection in other territories – including some geographically remote from Europe.  This article summarises relevant information about extension states, validation states and requesting protection

Page 1 of 1812345...10...Last »